The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction

Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction

(2011) A. Fujimaki et al.   PLACENTA

Adipocytokines and endothelial function in preeclamptic women

(2010) Toshitaka Mori et al.   HYPERTENSION RESEARCH

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion

(2008) Holger Stepan et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Placental Origins of Preeclampsia

(2008) Berthold Huppertz   HYPERTENSION

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine

Circulating and Placental Endoglin Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction and Preeclampsia

(2008) A JEYABALAN et al.   PLACENTA

Severe Intrauterine Growth Restriction Pregnancies Have Increased Placental Endoglin Levels

(2007) Yoav Yinon et al.   AMERICAN JOURNAL OF PATHOLOGY

Placental Productions and Expressions of Soluble Endoglin, Soluble fms-Like Tyrosine Kinase Receptor-1, and Placental Growth Factor in Normal and Preeclamptic Pregnancies

(2007) Yang Gu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Placental Expression of Soluble fms-Like Tyrosine Kinase 1 is Increased in Singletons and Twin Pregnancies with Intrauterine Growth Restriction

(2007) Ori Nevo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM